| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Apr 29, 2026 | Tax Payment (Shares) | $110.03 | 2,326 | 255,930 | 94,431 | May 01, 2026, 05:45 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Apr 29, 2026 | Option/RSU Exercise | $110.03 | 4,722 | 519,562 | 96,757 | May 01, 2026, 05:45 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Feb 10, 2026 | Sale | $117.52 | 10,235 | 1,202,844 | 92,035 | Feb 10, 2026, 04:04 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Feb 04, 2026 | Option/RSU Exercise | $56.04 | 15,087 | 845,475 | 117,357 | Feb 06, 2026, 04:12 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Feb 04, 2026 | Sale | $118.77 | 15,087 | 1,791,824 | 102,270 | Feb 06, 2026, 04:12 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Jan 26, 2026 | Award/Grant | $107.40 | 20,469 | 2,198,371 | 102,270 | Jan 28, 2026, 04:09 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Jan 27, 2025 | Award/Grant | $97.94 | 32,621 | 3,194,901 | 79,592 | Jan 29, 2025, 06:19 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Feb 09, 2024 | Option/RSU Exercise | $62.07 | 14,702 | 912,553 | 60,944 | Feb 12, 2024, 04:03 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Feb 09, 2024 | Sale | $125.50 | 14,702 | 1,845,083 | 46,242 | Feb 12, 2024, 04:03 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Jan 22, 2024 | Award/Grant | $119.43 | 25,760 | 3,076,517 | 46,242 | Jan 24, 2024, 04:10 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Jan 09, 2024 | Sale | $13.66 | 29,000 | 396,214 | 421,962 | Jan 11, 2024, 06:51 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Apr 21, 2023 | Gift | - | 627,705 | - | 0 | Oct 04, 2023, 05:46 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 01, 2023 | Option/RSU Exercise | $115.47 | 1,062 | 122,629 | 20,995 | May 03, 2023, 04:10 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 01, 2023 | Tax Payment (Shares) | $115.47 | 524 | 60,506 | 20,471 | May 03, 2023, 04:10 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Jan 23, 2023 | Award/Grant | $109.88 | 3,275 | 359,857 | 19,933 | Jan 25, 2023, 04:59 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 03, 2022 | Tax Payment (Shares) | $87.65 | 381 | 33,395 | 16,458 | May 04, 2022, 05:50 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 03, 2022 | Option/RSU Exercise | $87.65 | 773 | 67,753 | 16,839 | May 04, 2022, 05:50 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 01, 2022 | Option/RSU Exercise | $88.69 | 1,061 | 94,100 | 16,589 | May 03, 2022, 04:21 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 01, 2022 | Tax Payment (Shares) | $88.69 | 523 | 46,385 | 16,066 | May 03, 2022, 04:21 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Feb 24, 2022 | Award/Grant | $73.51 | 3,023 | 222,221 | 15,462 | Feb 28, 2022, 04:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Dec 07, 2021 | Sale | $20.48 | 15,900 | 325,630 | 1,316,000 | Dec 09, 2021, 09:21 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Nov 17, 2021 | Sale | $20.04 | 5,626 | 112,736 | 1,344,374 | Dec 09, 2021, 09:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Nov 19, 2021 | Sale | $20.20 | 13,474 | 272,226 | 1,330,900 | Dec 09, 2021, 09:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Nov 17, 2021 | Sale | $20.04 | 5,626 | 112,736 | 591,637 | Nov 19, 2021, 05:40 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Nov 19, 2021 | Sale | $20.20 | 13,474 | 272,226 | 578,163 | Nov 19, 2021, 05:40 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 04, 2021 | Tax Payment (Shares) | $75.98 | 238 | 18,083 | 12,310 | May 06, 2021, 04:55 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | May 04, 2021 | Option/RSU Exercise | $75.98 | 694 | 52,730 | 12,548 | May 06, 2021, 04:55 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Dean Y. Li | Director | Apr 20, 2021 | Conversion | - | 55,383 | - | 1,422,048 | Apr 22, 2021, 08:06 PM |
| MRK | | Merck & Co., Inc. | Dean Y. Li | Executive VP & President, MRL | Feb 26, 2021 | Award/Grant | $72.62 | 3,485 | 253,081 | 10,655 | Mar 02, 2021, 12:00 PM |
